1
WITH A SAMPLE OF HEALTHY SKIN THE SIZE OF THIS SQUARE
WE COVER SKIN TISSUE LOSS OF AN AREA FOUR TIMES THE SIZE OF THIS CARD
keradermlab@gmail.com Tel. (571) 2562631 Movil. (573) 3106183485 Calle 90 # 19A-49 oficina 801
Jorge Soto Partner CFO
Bogotá, Colombia
2
WHAT CAN CAUSE SKIN TISSUE LOSS BURNS
ULCERS
TRAUMAS
TUMORS
• 1% of the world populaGon will suffer at some point in his life a severe burn. • Annually, 1 million Europeans and 1.5 million Americans receive medical aTenGon for burns • Chronic wounds in USA affect 6.5 million with esGmated treatment costs of $25 billion per year. • 0.2% of the UK populaGon suffers chronic ulcers
Estrictamente Privado y Confidencial
3
CURRENT TREATMENT OF SKIN TISSUE LOSS
PARTIAL THICKNESS SKIN GRAFT
APPLICATION OF A PROTECTIVE COVERAGE IN THE AFFECTED AREA
4
PARTIAL THICKNESS SKIN GRAFT SEVERE PAIN
SIGNIFICANT SCARRING
COMPLICATIONS INHERENT TO ANY OTHER SURGICAL PROCEDURE Estrictamente Privado y Confidencial
5
ONE TRUE STORY
22 days old premature baby
Skin Hssue loss Sample CollecHon
5 to 7 days in Keraderm Lab
4×4in skin-‐cell-‐coated sheets
Estrictamente Privado y Confidencial
Keraderm Applied
6
KERADERM´S ADVANTAGES NO ADDITIONAL TRAUMA TO THE PATIENT AND IT IS PAINLESS
NO ADDITIONAL SCAR TO THAT OF THE AFFECTED AREA
THE PROCEDURE DOES NOT NEED TO BE CONDUCTED IN THE OR
IT IS MANAGEABLE BY NURSES AND PHYSICIANS OF ANY SPECIALTY
REPLICABLE ANYWHERE IN THE WORLD, INCLUDING DEVELOPING COUNTRIES
7
ONE TRUE STORY 30 DAYS AFTER APPLYING KERADERM
Estrictamente Privado y Confidencial
8
OTHER STORIES
PreoperaGve
15 Days A[er
30 Days A[er
9
OTHER STORIES 78 YEARS OLD TUMOR
PreoperaGve
30 Days A[er 10
OTHER STORIES 4 YEARS OLD TRAUMA
60 Days A[er
PreoperaGve
Estrictamente Privado y Confidencial
11
OTHER STORIES 2 YEARS OLD BURN
PreoperaGve
25 Days A[er Estrictamente Privado y Confidencial
12
ü PlasGc Surgeons:
MARKET
• Colombia: 657 • Bogota: 288 • Cali: 93 • Rest of the Country: 177 ü HMOs, and Hospitals in Bogota: • 22 State Social Enterprises (Hospitals) • 24 EPS • 14 HMOs ü InternaGonal Market
13
MARKET PATIENT IS THE FINAL USER OF KERADERM
• 1 million people suffer burns every year that require medical treatment
• 50,000 people suffer burns every year • 10% of which require hospitalizaGon
• 500.000 require hospitalizaGon • 25.000 go to burns unit
• 1% die as a consequence
• 10.000 die due to complicaGons
14
MARKETING CONFERENCES AND MEETINGS
PUBLICATIONS PRESENTATIONS TO PLASTIC SURGEONS
PRESENTATIONS TO HOSPITAL STAFF PUBLIC MEDIA
Estrictamente Privado y Confidencial
15
EVOLUTION 2010 • PatenGng process started (Patent CooperaGon Treaty)
2012 • Capital raised among investors • First Keraderm Lab
• Design of a clinical trial with a larger populaGon sample 2008
2012
• Skin cell culture method standardized. • SaGsfactory results in 10 paGents
2011 2010
2009
2010 2009
2008
2008
2008
2011 • Research study in 4 hospitals in Bogotá • 48 paGents were treated
• NaGonal PlasGc Surgery Congress
• The study followed legal and ethical guidelines.
• Granted the Guillermo Nieto Cano Award
• Won Ventures compeGGon
• Published in the Colombian Magazine of PlasGc Surgery 16
2013 OPENING OF A KERADERM LAB IN A MAJOR CITY IN COLOMBIA AND CONSOLIDATION OF OUR PATENT PROCESS
17
COMPETITORS THE RECONSTRUCTIVE LADDER PROCEDURE
ADVANTAGES
DISADVANTAGES
Healing by second intenGon
• No advantages idenGfied
• Longer healing process • Worst scars on treated areas
ParGal thickness skin gra[s
• Most commonly used procedure
Cadaver skin gra[
• Immediate availability
• Notorious addiGonal scarring and very painful • OR required under anesthesia • More risky and expensive • Not a definiGve procedure • The gra[ is always rejected
Skin subsGtutes
• Immediate availability
• AddiGonal procedures required • Higher costs
Donor skin cell cultures
• Immediate availability
• Extremely high costs of culture • Tests required to rule out incompaGbiliGes • Unavailable in developing countries
18
TEAM AND PARTNERS Gabriel Soto Legal Advisor
Jorge Soto CFO
Jenifer Gaona PlasGc Surgeon Product Developer
Rodrigo Soto PlasGc Surgeon CEO
Juan Zambrano PlasGc Surgeon Product Developer Eduardo Soto Chairman of the Board
19
WITH A SAMPLE OF HEALTHY SKIN THE SIZE OF THIS SQUARE
WE COVER SKIN TISSUE LOSS OF AN AREA FOUR TIMES THE SIZE OF THIS CARD
keradermlab@gmail.com Tel. (571) 2562631 Movil. (573) 3106183485 Calle 90 # 19A-49 oficina 801
Jorge Soto Partner CFO
Bogotá, Colombia
Estrictamente Privado y Confidencial
20
BURNS AND OTHER SKIN TISSUE LOSSES ARE CURRENTLY TREATED WITH PARTIAL THICKNESS SKIN GRAFTS, A PAINFUL PROCEDURE THAT GENERATES ADDITIONAL SCARRING AND HAS TO BE CARRIED OUT IN AN OR UNDER ANESTHESIA CARRYING COMPLICATIONS INHERENT TO SURGICAL PROCEDURES. KERADERM CONSISTS OF 4×4IN SKIN-‐ CELL-‐COATED SHEETS, GENERATED FROM CELLS CULTURED OF THE SAME PATIENT. IT IS A PAINLESS NON SURGICAL PROCEDURE WITH A SIGNIFICANT DECREASE IN COSTS AND WITH COMPLETE HEALING IN VERY SHORT PERIOD OF TIME 21